San Francisco, CA - August 12, 2025 - DeepScribe, the leading ambient AI solution for oncology, has announced the launch of a new podcast, “Beyond the Chart: Exploring the AI Frontier for Oncology.” Available on Apple Podcasts, Spotify, Amazon Music, iHeartRadio, and YouTube, the series features top minds and voices in oncology discussing how AI is driving real-world impact within one of medicine's most complex and critical specialties.
Hosted by DeepScribe co-founder and CEO Matthew Ko, “Beyond the Chart” presents candid, in-depth conversations with practicing oncologists, health system executives, technologists, and innovators shaping the future of complex care.
Today, ambient technology is moving beyond care documentation; it’s becoming an integrated layer of intelligence for clinical systems. As DeepScribe ambient AI has evolved from capturing visits to reshaping downstream workflows, Ko and guests explore the full capacity of the technology and how it can shape the future of cancer care — from improving clinical workflows to using patients’ voices as biomarkers that identify conditions.
The podcast launch includes episodes with three notable leaders in oncology, all at the forefront of healthcare technology:
- Dr. Gury Doshi, Medical Director at Texas Oncology; Pharmacy & Therapeutics Chair for the U.S. Oncology Network
- Larry Bilbrey, Director of Data Insights & Innovation at Tennessee Oncology; Senior Director of Innovation at OneOncology
- Dr. Stephen Speicher, Head of Clinical Oncology and Safety at Flatiron Health
Listeners and viewers can expect a new episode every two to three weeks.
“Ambient AI will be medicine’s operating system,” said Matthew Ko, DeepScribe co-founder and CEO. “‘Beyond the Chart’ brings together the leaders turning that vision into reality, sharing the insights that usually stay behind closed doors. Launching the show with such a remarkable group is a privilege, and I’m excited for others to hear their ideas and see the future they’re shaping.”
“Ambient AI will be medicine’s operating system,” said Matthew Ko, DeepScribe co-founder and CEO. “‘Beyond the Chart’ brings together the leaders turning that vision into reality, sharing the insights that usually stay behind closed doors. Launching the show with such a remarkable group is a privilege, and I’m excited for others to hear their ideas and see the future they’re shaping.”
“Beyond the Chart” is designed as a series of deep-dive exchanges that cut through the technology hype and focus on what’s truly working in the field. The show is for anyone in the oncology ecosystem: clinicians navigating digital transformation, health system leaders planning for innovation, and technologists building tools that truly serve patients and providers.
"This podcast is truly one of a kind,” said Dr. Gury Doshi, Medical Director at Texas Oncology. “It has a depth and focus on topics that really matter in oncology — and Matt is a skilled and thoughtful conversationalist. I’m honored to be part of the inaugural episode. I think the podcast is going to be a valued addition to the national dialogue on cancer care."
“Beyond the Chart” reinforces DeepScribe’s commitment to helping advance cancer care as the leader in ambient AI for oncology. The podcast serves as a new avenue to lead the way for education, inspiration, and collaboration across the cancer care continuum.
"It’s invaluable to find a platform where we can really dig into the intersection of high-performing technology and high-impact clinical care,” said Dr. Stephen Speicher, Head of Clinical Oncology and Safety at Flatiron Health. “Beyond the Chart” creates that space, and I’m thrilled to be part of the conversation.”
About DeepScribe
DeepScribe helps healthcare organizations make the most of every encounter with the Ambient Operating System – AI technology that produces accurate, context-focused documentation, coding intelligence, and real-time clinical insights. Founded in 2017, DeepScribe develops custom AI specifically for complex and chronic care workflows, and is the leading ambient AI for oncology: Organizations with DeepScribe see 42% of all cancer visits in the U.S. DeepScribe’s commitment to excellence was recognized in early 2025 with a 98.8* overall performance score by KLAS Research. To see how DeepScribe brings the joy of care back to medicine, visit deepscribe.ai.
(*limited data)
DeepScribe Media Contact
Norm Schrager
norm.schrager@deepscribe.tech
978-771-9976
text
